Bar-Shalev Amos

Bar-Shalev Amos is listed in filings as Director at Protalix BioTherapeutics, Inc.. This profile follows SEC Form 4 activity through Nov 19, 2025, including sale activity. Recent filings connect the profile to Protalix BioTherapeutics, Inc. (PLX). The current snapshot covers public activity from Sep 4, 2025 to Nov 19, 2025. Reported amounts are shown as $314 to $24.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.